| Name: | Anastrozole Diamide Impurity |
| Catalogue No. | VL2490003 |
| CAS No. | 120512-04-1 |
| Molecular Formula | C₁₇H₂₃N₅O₂ |
| Molecular Weight | 329.4 |
| Status | In-stock |
| IUPAC Name | α,α,α’,α’-Tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-benzenediacetamide |
| Description | Anastrozole Diamide Impurity/Anastrozole Diamide Impurity(CAS No: 120512-04-1) or α,α,α’,α’-Tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-benzenediacetamide, it is non-steroidal aromatase inhibitor and used to treat breast cancer in women after menopause. |
| References | Cuzick, Jack, et al. “Anastrozole for Prevention of Breast Cancer in High-Risk Postmenopausal Women (IBIS-II): An International, Double-Blind, Randomised Placebo-Controlled Trial.” Lancet (London, England), vol. 383, no. 9922, 2014, pp. 1041–8, www.ncbi.nlm.nih.gov/pubmed/24333009, 10.1016/S0140-6736(13)62292-8. Accessed 21 Nov. 2019. |
